HHS Office of Minority Health – Native American Heritage Month
#NativeAmericanHeritageMonth
#NativeAmericanHeritageMonth
Treatment with Lu 177-dotatate (Lutathera) and octreotide (Sandostatin) shrank tumors in people with advanced neuroendocrine tumors, a clinical trial found.
A fact sheet that summarizes the evidence linking overweight and obesity to the risk of various cancers and discusses how obesity affects cancer survivors.
Black and Hispanic patients nearing the end of life are less likely than White patients to get needed opioid medications for cancer pain.
Learn more about the inter-disciplinary field “data science” and its relationship with cancer research.
NCI SBIR Director Michael Weingarten and Rukiyah Van Dross-Anderson, Founder and CEO of SBIR-funded Claradele Pharmaceuticals discuss the journey from postdoc to biotech startup and…
The Cancer Currents blog provides news and research updates from the National Cancer Institute.
Skin cancer prevention approaches include avoiding risk factors like ultraviolet radiation that comes from the sun, sun lamps, and tanning beds. Learn more about the…
Suggested questions for patients to ask their doctors when they learn they have cancer and want to know what to expect next.
Disparities affect every aspect of the cancer experience. Tackling them will require advances and changes that go beyond the lab and doctor’s office.
Side effects are problems that occur when cancer treatment affects healthy tissues or organs. Learn about side effects caused by cancer treatment. Know what signs…